...
首页> 外文期刊>Circulation journal >Cystatin C-Based eGFR Is a Superior Prognostic Parameter to Creatinine-Based eGFR in Post-Endovascular Therapy Peripheral Artery Disease Patients
【24h】

Cystatin C-Based eGFR Is a Superior Prognostic Parameter to Creatinine-Based eGFR in Post-Endovascular Therapy Peripheral Artery Disease Patients

机译:基于胱抑素C的eGFR在血管内治疗后外周动脉疾病患者中优于基于肌酐的eGFR的预后参数

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Kidney dysfunction is reportedly associated with adverse outcome in patients with peripheral artery disease (PAD). Estimated glomerular filtration rate (eGFR), a recently popularized index for assessing kidney function, is calculated using serum creatinine or cystatin C. Compared with creatinine-based eGFR (eGFRcr), cystatin C-based eGFR (eGFRcys) is less affected by age, gender, and muscle mass. We hypothesized that eGFRcys is a feasible prognostic biomarker despite muscle sarcopenia in patients with PAD.
机译:背景:据报道,肾功能不全与外周动脉疾病(PAD)患者的不良结局有关。估计的肾小球滤过率(eGFR)是一种最近流行的评估肾功能的指标,是使用血清肌酐或半胱氨酸蛋白酶抑制剂C计算的。与基于肌酸酐的eGFR(eGFRcr)相比,基于胱抑素C的eGFR(eGFRcys)受年龄的影响较小,性别和肌肉质量。我们假设eGFRcys是一种可行的预后生物标志物,尽管PAD患者存在肌肉少肌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号